What is Intelligent Retinal Imaging Systems?
Intelligent Retinal Imaging Systems provides the IRIS platform, a sophisticated, cloud-based retinal screening software engineered to optimize diabetic eye care workflows. By offering a camera-agnostic solution, the company enables healthcare providers, including hospitals and health plans, to integrate retinal diagnostics seamlessly into existing clinical environments. This interoperability is critical for reducing care gaps and lowering systemic healthcare costs. The company's core value proposition lies in its ability to democratize access to high-quality diagnostic imaging, thereby facilitating early intervention for at-risk patient populations. As a leader in the digital health space, the firm continues to refine its software to meet the rigorous demands of large-scale health systems, ensuring that diagnostic accuracy and operational efficiency remain at the forefront of its service delivery model.
How much funding has Intelligent Retinal Imaging Systems raised?
Intelligent Retinal Imaging Systems has raised a total of $1.1M across 2 funding rounds:
Debt
$350K
Debt
$733K
Debt (2020): $350K with participation from PPP
Debt (2021): $733K led by PPP
Key Investors in Intelligent Retinal Imaging Systems
PPP
Public-Private Partnership
What's next for Intelligent Retinal Imaging Systems?
Looking ahead, the company is poised to leverage its recent capital influx to scale its market presence and enhance its diagnostic capabilities. With a focus on enterprise-level adoption, the firm will likely prioritize the expansion of its cloud infrastructure and the integration of advanced analytics to further streamline the screening process. The strategic deployment of these funds will be instrumental in navigating the complexities of the healthcare landscape, particularly as the industry shifts toward value-based care models. By continuing to bridge the gap between diagnostic technology and clinical practice, Intelligent Retinal Imaging Systems is set to maintain its competitive edge, driving long-term value for both its stakeholders and the patients it serves.
See full Intelligent Retinal Imaging Systems company page
